scholarly article | Q13442814 |
P50 | author | Nigel Stallard | Q43132046 |
Nick Parsons | Q53112989 | ||
Cornelia U Kunz | Q55473027 | ||
Tim Friede | Q58452336 | ||
P2093 | author name string | Susan Todd | |
P2860 | cites work | Galantamine for Alzheimer's disease and mild cognitive impairment | Q24244773 |
Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications | Q28652785 | ||
Testing and estimation in flexible group sequential designs with adaptive treatment selection | Q36327917 | ||
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts | Q36593604 | ||
Maximum inflation of the type 1 error rate when sample size and allocation rate are adapted in a pre-planned interim look. | Q40344979 | ||
Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease | Q43747318 | ||
Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim | Q44216598 | ||
Sequential designs for phase III clinical trials incorporating treatment selection | Q44315582 | ||
A confirmatory seamless phase II/III clinical trial design incorporating short-term endpoint information | Q45374094 | ||
Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology | Q46054107 | ||
A conditional error function approach for subgroup selection in adaptive clinical trials | Q46406244 | ||
Adaptive sample size calculations in group sequential trials | Q47213254 | ||
Modification of sample size in group sequential clinical trials | Q47213272 | ||
Designing a seamless phase II/III clinical trial using early outcomes for treatment selection: an application in multiple sclerosis | Q48152166 | ||
When is a seamless study desirable? Case studies from different pharmaceutical sponsors | Q50116411 | ||
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: opportunities and limitations. | Q51933435 | ||
Evaluation of experiments with adaptive interim analyses. | Q52364596 | ||
Monitoring pairwise comparisons in multi-armed clinical trials. | Q52376256 | ||
Adaptive Dunnett tests for treatment selection | Q57305793 | ||
Recursive Combination Tests | Q57305829 | ||
Flexible sequential designs for multi-arm clinical trials | Q57430497 | ||
A Comparison of Methods for Adaptive Treatment Selection | Q57430665 | ||
A group-sequential design for clinical trials with treatment selection | Q57430672 | ||
Designed extension of studies based on conditional power | Q70971455 | ||
Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches | Q74497643 | ||
Monitoring clinical trials with multiple arms | Q74497647 | ||
Are flexible designs sound? | Q80290439 | ||
P433 | issue | 23 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | phase II clinical trial | Q42824440 |
phase III clinical trial | Q42824827 | ||
P304 | page(s) | 3104-3115 | |
P577 | publication date | 2015-06-26 | |
P1433 | published in | Statistics in Medicine | Q7604438 |
P1476 | title | Flexible selection of a single treatment incorporating short-term endpoint information in a phase II/III clinical trial | |
P478 | volume | 34 |
Search more.